Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

894

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2010

Conditions
Hypertension
Interventions
DRUG

Telmisartan

Telmisartan 80mg

DRUG

Telmisartan

Telmisartan 80mg

DRUG

Hydrochlorothiazide

Hydrochlorothiazide25mg

Trial Locations (106)

Unknown

502.550.01008 Boehringer Ingelheim Investigational Site, Athens

502.550.01019 Boehringer Ingelheim Investigational Site, Mobile

502.550.01015 Boehringer Ingelheim Investigational Site, Lomita

502.550.01003 Boehringer Ingelheim Investigational Site, Colorado Springs

502.550.01014 Boehringer Ingelheim Investigational Site, Fort Lauderdale

502.550.01002 Boehringer Ingelheim Investigational Site, Louisville

502.550.01011 Boehringer Ingelheim Investigational Site, New Iberia

502.550.01009 Boehringer Ingelheim Investigational Site, New Orleans

502.550.01018 Boehringer Ingelheim Investigational Site, Olive Branch

502.550.01006 Boehringer Ingelheim Investigational Site, St Louis

502.550.01016 Boehringer Ingelheim Investigational Site, Charlotte

502.550.01007 Boehringer Ingelheim Investigational Site, Greensboro

502.550.01005 Boehringer Ingelheim Investigational Site, Cincinnati

502.550.01001 Boehringer Ingelheim Investigational Site, Cleveland

502.550.01017 Boehringer Ingelheim Investigational Site, Houston

502.550.01020 Boehringer Ingelheim Investigational Site, Houston

502.550.01012 Boehringer Ingelheim Investigational Site, San Antonio

502.550.01004 Boehringer Ingelheim Investigational Site, Arlington

502.550.35901 Boehringer Ingelheim Investigational Site, Sofia

502.550.35902 Boehringer Ingelheim Investigational Site, Sofia

502.550.35903 Boehringer Ingelheim Investigational Site, Sofia

502.550.35904 Boehringer Ingelheim Investigational Site, Sofia

502.550.35905 Boehringer Ingelheim Investigational Site, Sofia

502.550.35908 Boehringer Ingelheim Investigational Site, Sofia

502.550.35909 Boehringer Ingelheim Investigational Site, Sofia

502.550.35910 Boehringer Ingelheim Investigational Site, Sofia

502.550.35911 Boehringer Ingelheim Investigational Site, Sofia

502.550.35906 Boehringer Ingelheim Investigational Site, Stara Zagora

502.550.86004 Boehringer Ingelheim Investigational Site, Changsha

502.550.86003 Boehringer Ingelheim Investigational Site, Guangzhou, Guangdong Province

502.550.86008 Boehringer Ingelheim Investigational Site, Qingdao

502.550.86001 Boehringer Ingelheim Investigational Site, Shanghai

502.550.86002 Boehringer Ingelheim Investigational Site, Shanghai

502.550.86009 Boehringer Ingelheim Investigational Site, Shenyang

502.550.86007 Boehringer Ingelheim Investigational Site, Tianjin

502.550.86010 Boehringer Ingelheim Investigational Site, Zhengzhou

502.550.3302D Boehringer Ingelheim Investigational Site, Aigrefeuille S/Maine

502.550.3305I Boehringer Ingelheim Investigational Site, Aix-en-Provence

502.550.3305G Boehringer Ingelheim Investigational Site, Aubagne

502.550.3301H Boehringer Ingelheim Investigational Site, Briollay

502.550.3301K Boehringer Ingelheim Investigational Site, Cholet

502.550.3302I Boehringer Ingelheim Investigational Site, Corsept

502.550.3302C Boehringer Ingelheim Investigational Site, Donges

502.550.3302B Boehringer Ingelheim Investigational Site, La Montagne

502.550.3306A Boehringer Ingelheim Investigational Site, Louvigné-de-Bais

502.550.3303A Boehringer Ingelheim Investigational Site, Marseille

502.550.3303D Boehringer Ingelheim Investigational Site, Marseille

502.550.3303F Boehringer Ingelheim Investigational Site, Marseille

502.550.3304A Boehringer Ingelheim Investigational Site, Marseille

502.550.3304D Boehringer Ingelheim Investigational Site, Marseille

502.550.3304F Boehringer Ingelheim Investigational Site, Marseille

502.550.3304J Boehringer Ingelheim Investigational Site, Marseille

502.550.3305A Boehringer Ingelheim Investigational Site, Marseille

502.550.3301A Boehringer Ingelheim Investigational Site, Mûrs-Erigné

502.550.3301I Boehringer Ingelheim Investigational Site, Mûrs-Erigné

502.550.3302A Boehringer Ingelheim Investigational Site, Nantes

502.550.3302E Boehringer Ingelheim Investigational Site, Nantes

502.550.3301E Boehringer Ingelheim Investigational Site, Parçay-les-Pins

502.550.3303C Boehringer Ingelheim Investigational Site, Roquevaire

502.550.3302G Boehringer Ingelheim Investigational Site, Saint Aubin Les Châteaux

502.550.3306F Boehringer Ingelheim Investigational Site, Saint-Jouan-des-Guérets

502.550.3301F Boehringer Ingelheim Investigational Site, Segré

502.550.3307A Boehringer Ingelheim Investigational Site, Thouars

502.550.3301J Boehringer Ingelheim Investigational Site, Vihiers

502.550.99501 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99502 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99503 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99504 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99505 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99506 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99507 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.99508 Boehringer Ingelheim Investigational Site, Tbilisi

502.550.40002 Boehringer Ingelheim Investigational Site, Baia Mare Maramures

502.550.40003 Boehringer Ingelheim Investigational Site, Brăila

502.550.40001 Boehringer Ingelheim Investigational Site, Bucharest

502.550.40010 Boehringer Ingelheim Investigational Site, Bucharest

502.550.40012 Boehringer Ingelheim Investigational Site, Bucharest

502.550.40009 Boehringer Ingelheim Investigational Site, Cluj-Napoca

502.550.40011 Boehringer Ingelheim Investigational Site, Cluj-Napoca

502.550.40006 Boehringer Ingelheim Investigational Site, Iași

502.550.40004 Boehringer Ingelheim Investigational Site, Oradea

502.550.40005 Boehringer Ingelheim Investigational Site, Sibiu

502.550.40008 Boehringer Ingelheim Investigational Site, Tg. Mures

502.550.07001 Boehringer Ingelheim Investigational Site, Moscow

502.550.07002 Boehringer Ingelheim Investigational Site, Moscow

502.550.07003 Boehringer Ingelheim Investigational Site, Moscow

502.550.07004 Boehringer Ingelheim Investigational Site, Moscow

502.550.07005 Boehringer Ingelheim Investigational Site, Moscow

502.550.07006 Boehringer Ingelheim Investigational Site, Moscow

502.550.07007 Boehringer Ingelheim Investigational Site, Saint Petersburg

502.550.07008 Boehringer Ingelheim Investigational Site, Saint Petersburg

502.550.07009 Boehringer Ingelheim Investigational Site, Saint Petersburg

502.550.07010 Boehringer Ingelheim Investigational Site, Saint Petersburg

502.550.82008 Boehringer Ingelheim Investigational Site, Cheonan

502.550.82009 Boehringer Ingelheim Investigational Site, Daegu

502.550.82001 Boehringer Ingelheim Investigational Site, Goyang

502.550.82003 Boehringer Ingelheim Investigational Site, Gwangju

502.550.82002 Boehringer Ingelheim Investigational Site, Seoul

502.550.82005 Boehringer Ingelheim Investigational Site, Seoul

502.550.82006 Boehringer Ingelheim Investigational Site, Seoul

502.550.82007 Boehringer Ingelheim Investigational Site, Seoul

502.550.82011 Boehringer Ingelheim Investigational Site, Seoul

502.550.82012 Boehringer Ingelheim Investigational Site, Seoul

502.550.82013 Boehringer Ingelheim Investigational Site, Seoul

502.550.82004 Boehringer Ingelheim Investigational Site, Suwon

502.550.82010 Boehringer Ingelheim Investigational Site, Wŏnju

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY